Evidence map›Paper›PMID 38497844›Full record

ArticleClinical and translational allergy2024

A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report.

Anne-Lotte Redel, Wojciech Feleszko, Alessandra Arcolaci, Francesca Cefaloni, Marina Atanaskovic-Markovic, Gert-Jan Braunstahl, Cristina Boccabella, Matteo Bonini, Aspasia Karavelia, Eefje Louwers and 9 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 11 countries.

Anne-Lotte RedelDepartment of Pulmonology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.ORCID https://orcid.org/0009-0002-2990-9069
Wojciech FeleszkoDepartment of Pediatric Allergy and Pneumonology, Medical University of Warsaw, Warsaw, Poland.ORCID https://orcid.org/0000-0001-6613-2012
Alessandra ArcolaciImmunology Unit, University of Verona and General Hospital Borgo Roma Hospital, Verona, Italy.
Francesca CefaloniUniversità Cattolica del Sacro Cuore, Rome, Italy.ORCID https://orcid.org/0009-0004-6929-0912
Marina Atanaskovic-MarkovicFaculty of Medicine, University of Belgrade, University Children's Hospital, Belgrade, Serbia.
Gert-Jan BraunstahlDepartment of Pulmonology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Cristina BoccabellaFaculty of Medicine and Surgery, Respiratory Medicine, Catholic University of the Sacred Heart, Milan, Italy.
Matteo BoniniDepartment of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
Aspasia KaraveliaDepartment of Ear-Nose-Throat Surgery, General Hospital of Nafplio, Nafplio, Greece.
Eefje LouwersGeneral Practice, Gezondheidscentrum Berkel en Rodenrijs, Berkel en Rodenrijs, The Netherlands.
Norbert MülleneisenAsthma-Allergiezentrum Leverkusen, Leverkusen, Germany.
Liam O'MahonyDepartment of Medicine, School of Microbiology, APC Microbiome Ireland, National University of Ireland, Cork, Ireland.ORCID https://orcid.org/0000-0003-4705-3583
Laura PiniDepartment of Clinical and Experimental Sciences, Respiratory Medicine Unit, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.
Anna RapiejkoDepartment of Pediatric Allergy and Pneumonology, Medical University of Warsaw, Warsaw, Poland.
Esmeralda ShehuInternal Medicine Department, Durres Regional Hospital, Durres, Albania.
Milena SokolowskaSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Zürich, Switzerland.
Eva UntersmayrInstitute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-1963-499X
Gerdien Tramper-StrandersDepartment of Pulmonology, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-0228-5375
EAACI Task Force on Conscious and Rational use of Antibiotics in Allergic Diseases
Erasmus MC · NLUniversità Cattolica del Sacro Cuore · ITMedical University of Warsaw · PLAleksandër Moisiu University · ALAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITGeneral Hospital of Nafplio · GRKlinikum Leverkusen · DEMedical University of Vienna · ATNational University of Ireland · IEUniversity of Belgrade · RSUniversity of Verona · ITUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGuidelines recommend treating asthma exacerbations (AAEs) with bronchodilators combined with inhaled and/or systemic corticosteroids. Indications for antibiotic prescriptions for AAEs are usually not incorporated although the literature shows antibiotics are frequently prescribed.

aimTo investigate the antibiotic prescription rates in AAEs and explore the possible determining factors of those practices.

methodsA digital survey was created to determine the antibiotic prescription rates in AAEs and the influencing factors for the prescription practices. The survey was distributed among European academy of allergy and clinical immunology (EAACI) members by mass emailing and through regional/national societies in the Netherlands, Italy, Greece, and Poland. Furthermore, we retrieved local antibiotic prescription rates.

resultsIn total, 252 participants completed the survey. Respondents stated that there is a lack of guidelines to prescribe antibiotics in AAEs. The median antibiotic prescription rate in this study was 19% [IQR: 0%-40%] and was significantly different between 4 professions: paediatrics 0% [IQR: 0%-37%], pulmonologists 25% [IQR: 10%-50%], general practitioners 25% [IQR: 0%-50%], and allergologists 17% [IQR: 0%-33%]) (p = 0.046). Additional diagnostic tests were performed in 71.4% of patients before prescription and the most common antibiotic classes prescribed were macrolides (46.0%) and penicillin (42.9%). Important clinical factors for health care providers to prescribe antibiotics were colorised/purulent sputum, abnormal lung sounds during auscultation, fever, and presence of comorbidities.

conclusionIn 19% of patients with AAEs, antibiotics were prescribed in various classes with a broad range among different subspecialities. This study stresses the urgency to compose evidence-based guidelines to aim for more rational antibiotic prescriptions for AAE.

Indexed as

antibioticsasthmaexacerbationsurvey

Identifiers

PMID38497844
PMCPMC10946284
OpenAlexW4392911333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.